Skip to main content
About us
Products
Health matters
Investors
Media center
Employment
EN
Choose a country
Krka around the world
For Healthcare Professionals
Access extended content about our products and healthcare studies.
Login
Do you want to logout?
Logout
About us
Products
Health matters
Investors
Media center
Employment
About us
Krka at a glance
Management
International presence
Sustainability (ESG)
Products
Therapeutic areas
Clinically proven
Science and technology
Quality
Our products
Health matters
Articles
Podcasts
Investors
Financial reports
Share trading
Financial calendar
Shareholder structure
Corporate governance
Investor information
Benefits of owning Krka shares
Media center
News
Multimedia center
Employment
Join us
Why work at Krka?
Areas of work
Employees share their stories
Krka at a glance
Our mission, vision and values
Development strategy
Areas of operation
History
Identity card
Management
Management board
Supervisory board
Sustainability (ESG)
Environment
Social
Governance
Krka ESG Rating
Therapeutic areas
Cardiovascular diseases
Gastrointestinal disorders
Central nervous system diseases
Pain
Diabetes
Cough and cold
Parasites in dogs and cats
Science and technology
State-of-the-art technology
Achievements
Quality
Ensuring quality
Dedicated to quality
Quality management
Investor information
Corporate releases
Investor conferences
About Krka shares
Dividends
Documents
Frequently asked questions
Areas of work
Marketing
Sales
Corporate performance management
Regulatory affairs and pharmacovigilance
Production
Quality management
Engineering and technical services
Research and development
Supply chain
Information technology
Environment
Strategy and environmental policy
Energy and natural resources
Environmental impact
Social
Product quality and patient safety
Talent attraction and retention
Accessible healthcare
Social responsibility
Governance
Good leadership and governance practices
Compliance, integrity and transparency
State-of-the-art technology
Development and production of APIs
Development of pharmaceutical products
Analytical techniques and research
Production of finished products
Achievements
Bilayer tablets
Prolonged-release tablets
Osmotic-controlled release innovation
Ensuring quality
Development and production of APIs
Provision of raw materials
Development and production of pharmaceutical forms
Quality assurance
Finished product approval
Product distribution
Dispensing of medicines and their use
About Krka shares
Share split
Dividends
Dividends paid
Documents
Annual General Meeting
Corporate governance documents
Disclaimer
Information memorandum
Social responsibility
Partnership
Dedicated to sport
Dedicated to culture
Dedicated to science
Supporting healthcare institutions
Charity and volunteering
Good leadership and governance practices
Personal data protection
Compliance, integrity and transparency
Integrity and compliance
Krka’s Code of conduct
Chief Compliance Officer
Transparency and reporting
FONT
SIZE
-
0
+
LOWER/UPPERCASE
Lower
UPPER
STYLE
Normal
Bold
THEME
None
Black
White
Show
images
Hide
Images
Reset
Close
Home
About us
International presence
TAD Pharma GmbH
TAD Pharma GmbH